About this trial
The study aim to study The Adjunctive therapy with vaginal tablets containing Lactobacillus acidophilus KS400 and low-dose Estriol (Gynoflor®) in addition to standard tocolytic treatment administered once daily for 6 days starting the same day as tocolytic therapy, in pregnant women diagnosed with preterm labor at gestational age 24-33 weeks .Primary Outcome is the rate of pregnancy prolongation beyond 7 days after initiation of tocolytic therapy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
Age under 18 years or 35 years and older
Incomplete course of Gynoflor® (less than 6 days of use)
Presence of contraindications to tocolysis
Preterm premature rupture of membranes (PPROM)
Trial design
Parallel
Treatments tested in this trial
Gynoflor
DrugParticipants in this group will receive Gynoflor vaginal tablets (containing Lactobacillus acidophilus and estriol) administered once daily for 7 consecutive days. This intervention aims to evaluate whether restoring vaginal flora with Gynoflor can prolong pregnancy time compared to no intervention.
Treatment groups
Trial outcomes
Primary outcomes
proportion of women remaining pregnant more than 7 days after initiation of tocolytic
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: